Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer have?
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer has 5,784 citations in the OpenAlex counts ScholarIQ stores.
When was Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer published?
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer has 2006 year in the ScholarIQ index.
What is the open-access status of Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer?
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer?
The DOI for Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer is on the source record.
What is the PMID of Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer?
The PMID for Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer is on the source record.
What is the OpenAlex record for Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer?
The OpenAlex for Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer is on the source record.